Ameriprise
TSVT

Ameriprise’s 2seventy bio TSVT Stock Holding History

Ameriprise’s Portfolio TSVT Stock Details TSVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,938
Closed -$117K – 3943
2024
Q1 		$117K Sell
21,938
-21,829
-50% -$103K ﹤0.01% 3764
2023
Q4 		$187K Sell
43,767
-70,592
-62% -$217K ﹤0.01% 3734
2023
Q3 		$448K Buy
114,359
+40,688
+55% +$267K ﹤0.01% 3446
2023
Q2 		$746K Buy
73,671
+63,145
+600% +$669K ﹤0.01% 3288
2023
Q1 		$107K Buy
+10,526
New +$120K ﹤0.01% 3817

Other funds holding TSVT

KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Ameriprise's TSVT Position: Q2 2024 in Review

Ameriprise sold out of 2seventy bio (TSVT) in Q2 2024, closing a stake of 21,938 shares — an estimated $117K sold.

Ameriprise first reported a position in TSVT in Q1 2023 and held it in 5 quarters. The position peaked at $746K in Q2 2023. 115 funds tracked by Wall St. Rank hold TSVT as of Q2 2024.

  • Ameriprise reported no remaining 2seventy bio position as of Q2 2024 after selling out during the quarter.
  • Ameriprise sold 21,938 2seventy bio shares in Q2 2024, an estimated $117K.
  • Ameriprise first reported a position in 2seventy bio in Q1 2023 and held it in 5 quarters.
  • Ameriprise's 2seventy bio position peaked at $746K in Q2 2023.
  • 115 funds tracked by Wall St. Rank held 2seventy bio as of Q2 2024.

Based on Ameriprise's 13F filing for Q2 2024, filed 14 Aug 2024.